§ BIOTECHNOLOGY
USD · Biotechnology

AVBP

ARRIVENT BIOPHARMA INC
USDSector · Biotechnology
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
111 increased/new, 36 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
MONTANOVA CAPITAL, LLC4.4M2.6%+7%
INFINITUM ASSET MANAGEMENT, LLC4.1M12.0%+1%
HHLR ADVISORS, LTD.3.9M5.4%±0%
ORBIMED ADVISORS LLC3.0M1.4%±0%
Fidelity Management3.0M0.0%−19%
BlackRock, Inc.2.5M0.0%+7%
◇ AC INTELLIGENCE

Top institutional owners for AVBP as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER76.0% · 93 holders
DEALER / BANK8.5% · 18 holders
PASSIVE / INDEX8.3% · 7 holders
QUALITY / COMPOUNDER7.9% · 9 holders
TACTICAL / MACRO2.8% · 4 holders
ACTIVIST0.8% · 1 holder
SYSTEMATIC / QUANT0.4% · 6 holders
INCOME / DEFENSIVE0.1% · 4 holders
GROWTH / MOMENTUM0.1% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for AVBP in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention AVBP yet.